Jonathan Zalevsky

Analyst

Chief of Research and Development

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

NKTR

Current role

10 calls Latest call 2026-05-07

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Nektar Therapeutics (NKTR)	Chief Research and Development Officer	$717,560	—	$271,750	$861,497	$452,000	$17,551	$2,320,358
2024	Nektar Therapeutics (NKTR)	Chief Research and Development Officer	$703,490	—	—	$460,420	$431,885	$15,825	$1,611,620
2023	Nektar Therapeutics (NKTR)	Chief Research and Development Officer	$703,490	—	—	$178,300	$400,989	$490,585	$1,773,364
2022	Nektar Therapeutics (NKTR)	Chief Research and Development Officer	$703,490	—	$1,325,673	$1,778,436	$253,256	$289,625	$4,350,480
2021	Nektar Therapeutics (NKTR)	Chief Research and Development Officer	$683,000	—	$2,391,094	$1,397,498	$471,270	$8,385	$4,951,247

Earnings-call appearances and filed executive appointments or departures, newest first.